| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/1998 | WO1998028265A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 07/02/1998 | WO1998028264A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 07/02/1998 | WO1998028263A1 Creatine pyruvates and method for their production |
| 07/02/1998 | WO1998028257A1 Aromatic amine derivatives having nos inhibitory effect |
| 07/02/1998 | WO1998028027A1 Combatting infection in delivery systems |
| 07/02/1998 | WO1998028011A1 Compositions containing lipophilic oligosaccharide antibiotic and albumin |
| 07/02/1998 | WO1998028009A1 Pharmaceutical compositions for freeze drying |
| 07/02/1998 | WO1998027990A1 Methods of elevating amounts of hyaluronan in the human body |
| 07/02/1998 | WO1998027989A1 Palatable hydroxypropyl methylcellulose ether powder with specified particle size |
| 07/02/1998 | WO1998027988A1 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| 07/02/1998 | WO1998027987A1 New treatment for joint inflammation |
| 07/02/1998 | WO1998027986A1 Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes |
| 07/02/1998 | WO1998027985A1 Topical application of opioid drugs such as morphine for relief of itching and skin disease or irritation |
| 07/02/1998 | WO1998027984A1 METHOD OF PRODUCING ANALGESIA BY ADMINISTRATION OF 1,2,3,4-TETRAHYDROBENZO-[b]THIENO[2,3-c]PYRIDINE AND DERIVATIVES |
| 07/02/1998 | WO1998027983A1 A method of treating hypercholesterolemia and related disorders |
| 07/02/1998 | WO1998027982A1 Composition containing ascorbic acid |
| 07/02/1998 | WO1998027981A1 An aqueous formulation comprising bambuterol and the use thereof |
| 07/02/1998 | WO1998027979A1 Heterocyclic inhibitors of microsomal triglyceride transfer protein and method |
| 07/02/1998 | WO1998027978A1 Dermatologic preparation |
| 07/02/1998 | WO1998027977A1 Delivering therapeutically effective amounts of pyruvate |
| 07/02/1998 | WO1998027976A1 Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists |
| 07/02/1998 | WO1998027975A1 Poly(adp-ribose) polymerase inhibitors to treat diseases associated with cellular senescence |
| 07/02/1998 | WO1998027974A1 Antidiabetic agents |
| 07/02/1998 | WO1998027973A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
| 07/02/1998 | WO1998027972A2 Anti-amyloidogenic agents |
| 07/02/1998 | WO1998027971A1 Pharmaceutical composition for treating fecal incontinence and anal itch |
| 07/02/1998 | WO1998027970A2 Treatment of diseases or prevention of cellular damage caused by oxygen-containing free radicals |
| 07/02/1998 | WO1998027969A2 Antimicrobial phenazine compounds |
| 07/02/1998 | WO1998027968A1 Novel topical formulation of anti-inflammatory drugs for the treatment of localized pain |
| 07/02/1998 | WO1998027967A1 Release-controlled coated tablets |
| 07/02/1998 | WO1998027965A1 Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
| 07/02/1998 | WO1998027961A2 Antitussive drugs delivered by partially coated ion exchange resins |
| 07/02/1998 | WO1998027960A2 A nitroimidazole gel composition |
| 07/02/1998 | WO1998027959A2 New aqueous medicament preparations for the production of propellent gas-free aerosols |
| 07/02/1998 | WO1998027931A2 Salts of acetaminophen |
| 07/02/1998 | WO1998027930A2 New use of aminopiperazine derivatives |
| 07/02/1998 | WO1998027929A2 Therapeutic gestagens for the treatment of premenstrual dysphoric disorder |
| 07/02/1998 | WO1998027817A1 Endoparasiticidal and ectoparasiticidal agents |
| 07/02/1998 | WO1998027815A1 Substituted aminoquinolines as modulators of chemokine receptor activity |
| 07/02/1998 | WO1998019673A3 Anti-viral agents and methods relating to the use thereof |
| 07/02/1998 | WO1998017315A3 Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
| 07/02/1998 | WO1998014445A3 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 07/02/1998 | WO1998008974A3 Catalytic nucleic acid and its medical use |
| 07/02/1998 | DE3645312C2 Dermatological compsn. contg. 5-acyl-salicylic acid derivs. |
| 07/02/1998 | DE19757627A1 Azulenderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzung, die diese Verbindungen enthält Azulene derivatives, processes for their preparation and pharmaceutical composition containing these compounds |
| 07/02/1998 | DE19654750A1 Verwendung von Wirkstoffen mit Östrogen-Wirkung zur Vorbeugung und Behandlung von Makuladegeneration Use of agents with estrogen effect in the prevention and treatment of macular degeneration |
| 07/02/1998 | DE19654445A1 Low toxicity antiinflammatory agent, e.g. for treating dermatitis |
| 07/02/1998 | CA2276034A1 Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors |
| 07/02/1998 | CA2275964A1 Synthesis of nucleosides and polynucleotides |
| 07/02/1998 | CA2275955A1 Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them |
| 07/02/1998 | CA2275933A1 Aromatic amine derivatives having nos inhibiting action |
| 07/02/1998 | CA2275902A1 Palatable hydroxypropyl methylcellulose ether powder with specified particle size |
| 07/02/1998 | CA2275796A1 Nitrogen containing heteroaromatics as factor xa inhibitors |
| 07/02/1998 | CA2275683A1 Meiosis regulating compounds |
| 07/02/1998 | CA2275681A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
| 07/02/1998 | CA2275665A1 Nitromethylthiobenzene derivatives as aldose reductase inhibitors |
| 07/02/1998 | CA2275601A1 Imidazopyridazines |
| 07/02/1998 | CA2275429A1 A nitroimidazole gel composition |
| 07/02/1998 | CA2275394A1 Antidiabetic agents |
| 07/02/1998 | CA2275373A1 Compositions containing lipophilic oligosaccharide antibiotic and albumin |
| 07/02/1998 | CA2275359A1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 07/02/1998 | CA2275318A1 New use of aminopiperazine derivatives |
| 07/02/1998 | CA2275312A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 07/02/1998 | CA2275271A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 07/02/1998 | CA2275174A1 Salts of acetaminophen |
| 07/02/1998 | CA2275163A1 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists |
| 07/02/1998 | CA2274769A1 New treatment for joint inflammation |
| 07/02/1998 | CA2274586A1 Methods for detecting and inhibiting the rna component of telomerase |
| 07/02/1998 | CA2274117A1 Novel compounds with analgesic effect |
| 07/02/1998 | CA2272453A1 Benzoylalkyl-1,2,3,6-tetrahydropyridines |
| 07/02/1998 | CA2272305A1 Cycloalkyl, lactam, lactone and related compounds as .beta.-amyloid peptide release inhibitors |
| 07/02/1998 | CA2269679A1 Antitussive drugs delivered by partially coated ion exchange resins |
| 07/02/1998 | CA2268774A1 6-thio-substituted paclitaxels |
| 07/02/1998 | CA2247348A1 Antimicrobial phenazine compounds |
| 07/02/1998 | CA2246787A1 Novel compounds |
| 07/02/1998 | CA2244952A1 Systems and methods for quantifying photoreactions in light activated materials |
| 07/02/1998 | CA2243085A1 An aqueous formulation comprising bambuterol and the use thereof |
| 07/02/1998 | CA2219265A1 Human cardiac/brain tolloid-like protein |
| 07/01/1998 | EP0850948A1 Propiophenone derivatives and process for preparing the same |
| 07/01/1998 | EP0850947A1 Crystalline powdery saccharide, its preparation and uses |
| 07/01/1998 | EP0850940A1 Ellipticine derivatives, their preparation and pharmaceutical compositions containing them |
| 07/01/1998 | EP0850939A1 Ellipticine derivatives, their preparation and pharmaceutical compositions containing them |
| 07/01/1998 | EP0850926A2 Difluoroprostaglandin derivatives and their use |
| 07/01/1998 | EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents |
| 07/01/1998 | EP0850909A1 Stilbene compounds with adamantyl group, compositions containing the same and uses |
| 07/01/1998 | EP0850648A2 Combination of thrombolytically active proteins and anticoagulants and uses thereof |
| 07/01/1998 | EP0850647A1 Application of 11-substituted steroids for the preparation of medicaments with dissociated estrogenic activity |
| 07/01/1998 | EP0850646A1 Liposome preparations of indolocarbazole derivatives |
| 07/01/1998 | EP0850641A1 Use of Sophorolipides as a stimulating agent of the metabolism of dermic fibroblasts |
| 07/01/1998 | EP0850408A1 METHOD FOR MEASURING NITROSYL (FeII)-HEMOGLOBIN |
| 07/01/1998 | EP0850319A1 Method for modulating cell apoptosis |
| 07/01/1998 | EP0850316A1 Cryptophycins from aberrant biosynthesis |
| 07/01/1998 | EP0850305A2 Compounds and methods for diagnosis of tuberculosis |
| 07/01/1998 | EP0850301A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 07/01/1998 | EP0850300A1 Method of modulating gene expression with reduced immunostimulatory response |
| 07/01/1998 | EP0850251A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 07/01/1998 | EP0850247A1 Pyrimidine nucleoside derivative |
| 07/01/1998 | EP0850246A2 Pyrimidine nucleoside derivatives |
| 07/01/1998 | EP0850244A1 Toxoplasma gondii glycoconjugates |
| 07/01/1998 | EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |